PDS Biotechnology(DE:EU6)
€0.69-0.10 (-12.15%)
DE:EU6
PDS Biotechnology financials statements
€0.69
At close:-0.10 (-12.15%)
PDS Biotechnology (EU6) Income Statement
2 Followers
PDS Biotechnology Income Statement
Last quarter (Q3 2026), PDS Biotechnology's total revenue was $0.00. In Q3, PDS Biotechnology's net income was $-7.62M. See PDS Biotechnology’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -59.79K | $ -57.33K | $ 0.00 | $ 0.00 | |
| $ 31.54M | $ 36.26M | $ 43.05M | $ 41.67M | $ 21.44M | |
| Depreciation and Amortization | $ 21.84K | $ 21.11M | $ 57.33K | $ 86.00 | $ 5.36K |
| $ -30.30M | $ -12.69M | $ -40.08M | $ -40.74M | $ -21.43M | |
| $ -31.54M | $ -36.32M | $ -43.05M | $ -41.67M | $ -21.44M | |
| $ -4.12M | $ -2.16M | $ -1.30M | $ -381.34K | $ 4.35K | |
| $ -35.67M | $ -38.48M | $ -44.35M | $ -42.05M | $ -21.43M | |
| $ -34.50M | $ -37.61M | $ -42.94M | $ -40.85M | $ -16.92M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.74 | $ -1.03 | $ -1.39 | $ -1.43 | $ -0.66 |
| Diluted EPS | $ -0.74 | $ -1.03 | $ -1.39 | $ -1.43 | $ -0.66 |
| Weighted Average Shares Outstanding | 46.38M | 36.45M | 30.95M | 28.60M | 25.60M |
| Weighted Average Shares Outstanding (Diluted) | 46.38M | 36.45M | 30.95M | 28.60M | 25.60M |
Currency in USD

